This company listing is no longer active
Hofseth BioCare (HBCO) Stock Overview
Produces and sells health nutritional products for humans and pets in Norway, the United Kingdom, France, Belgium, Italy, Germany, Turkey, rest of Europe, Japan, Asia, and the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
HBCO Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
Hofseth BioCare ASA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NOK 2.70 |
| 52 Week High | NOK 2.70 |
| 52 Week Low | NOK 2.70 |
| Beta | 0.62 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -71.82% |
| 5 Year Change | 18.94% |
| Change since IPO | 44.39% |
Recent News & Updates
Recent updates
Shareholder Returns
| HBCO | GB Biotechs | GB Market | |
|---|---|---|---|
| 7D | 0% | -1.6% | 0.01% |
| 1Y | n/a | -4.5% | 18.5% |
Return vs Industry: Insufficient data to determine how HBCO performed against the UK Biotechs industry.
Return vs Market: Insufficient data to determine how HBCO performed against the UK Market.
Price Volatility
| HBCO volatility | |
|---|---|
| HBCO Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 6.9% |
| Market Average Movement | 5.1% |
| 10% most volatile stocks in GB Market | 10.4% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: HBCO has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine HBCO's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 60 | Jon Odegard | www.hofsethbiocare.com |
Hofseth BioCare ASA operates as a consumer and pet health ingredient supplier in Norway and internationally. Its products include Brilliant salmon oil; OmeGo salmon oil for the maintenance of healthy cholesterol, joint, eye, brain, and cardiovascular function; ProGo, a salmon protein hydrolysate powder for treatment of irondeficiency anaemia, irritable bowel syndrome, and sarcopenia; CalGo, a marine calcium powder produced to support cartilage function, joint health, and bone strength; CollaGo; and PetGo, a non-soluble protein. Hofseth BioCare ASA was incorporated in 2009 and is headquartered in Ålesund, Norway.
Hofseth BioCare ASA Fundamentals Summary
| HBCO fundamental statistics | |
|---|---|
| Market cap | NOK 1.09b |
| Earnings (TTM) | -NOK 139.56m |
| Revenue (TTM) | NOK 134.43m |
Is HBCO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HBCO income statement (TTM) | |
|---|---|
| Revenue | NOK 134.43m |
| Cost of Revenue | NOK 121.71m |
| Gross Profit | NOK 12.72m |
| Other Expenses | NOK 152.28m |
| Earnings | -NOK 139.56m |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
Aug 25, 2023
| Earnings per share (EPS) | -0.35 |
| Gross Margin | 9.46% |
| Net Profit Margin | -103.81% |
| Debt/Equity Ratio | 89.7% |
How did HBCO perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/06/27 21:28 |
| End of Day Share Price | 2023/03/30 00:00 |
| Earnings | 2023/03/31 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Hofseth BioCare ASA is covered by 1 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jonas Peciulis | Norne Securities AS |